6 Risk Stratification in SM
6.1 REMA Score
6.2 Global prognostic score for mastocytosis (GPSM)
6.3 MARS Score
- For patients with SM-AHN
- It was developed in the era of midostaurin
- We do not know if it still holds true in the era of avapritinib or bezuclastinib